These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of centrally acting sympatholytic agents in the management of hypertension. Oster JR; Epstein M Arch Intern Med; 1991 Aug; 151(8):1638-44. PubMed ID: 1872668 [TBL] [Abstract][Full Text] [Related]
5. Seizure associated with bupropion and guanfacine. Namerow LB J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):2-3. PubMed ID: 9893404 [No Abstract] [Full Text] [Related]
6. Characteristics of children and adolescents with mental retardation and frequent outwardly directed aggressive behavior. Davidson PW; Jacobson J; Cain NN; Palumbo D; Sloane-Reeves J; Quijano L; Van Heyningen J; Giesow V; Erhart J; Williams T Am J Ment Retard; 1996 Nov; 101(3):244-55. PubMed ID: 8933899 [TBL] [Abstract][Full Text] [Related]
7. [Acute psychotic episodes in adolescents with mental retardation and the concept of decompensation in pediatric psychiatry]. Schachter M Ann Med Psychol (Paris); 1972 Apr; 1(4):507-28. PubMed ID: 5078352 [No Abstract] [Full Text] [Related]
8. Guanfacine for Tourette's disorder. Fras I J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):3-4. PubMed ID: 8567607 [No Abstract] [Full Text] [Related]
9. Guanfacine use in children with attention deficit hyperactivity disorder. Cohn LM; Caliendo GC Ann Pharmacother; 1997; 31(7-8):918-9. PubMed ID: 9220058 [TBL] [Abstract][Full Text] [Related]
10. Effects of Snoezelen room, Activities of Daily Living skills training, and Vocational skills training on aggression and self-injury by adults with mental retardation and mental illness. Singh NN; Lancioni GE; Winton AS; Molina EJ; Sage M; Brown S; Groeneweg J Res Dev Disabil; 2004; 25(3):285-93. PubMed ID: 15134793 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079 [TBL] [Abstract][Full Text] [Related]
13. Paradoxical Hypertensive Urgency in a Child After Initiation of Guanfacine. Luber MJ; Coffey BJ; Gamms SH J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):466-468. PubMed ID: 28613939 [No Abstract] [Full Text] [Related]
14. Developmental differences in the symptomatology of psychiatric inpatients with and without mild mental retardation. Glick M; Zigler E Am J Ment Retard; 1995 Jan; 99(4):407-17. PubMed ID: 7695882 [TBL] [Abstract][Full Text] [Related]
16. Managing aggression in the mentally retarded child. van der Merwe SE Nurs RSA; 1992 Mar; 7(3):41-4. PubMed ID: 1584296 [No Abstract] [Full Text] [Related]
17. Guanfacine in children with autism and/or intellectual disabilities. Handen BL; Sahl R; Hardan AY J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703 [TBL] [Abstract][Full Text] [Related]
18. Mental illness and mental retardation: cause or coincidence? Russell AT; Tanguay PE Am J Ment Defic; 1981 May; 85(6):570-4. PubMed ID: 7270571 [TBL] [Abstract][Full Text] [Related]
19. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Neylan TC; Lenoci M; Samuelson KW; Metzler TJ; Henn-Haase C; Hierholzer RW; Lindley SE; Otte C; Schoenfeld FB; Yesavage JA; Marmar CR Am J Psychiatry; 2006 Dec; 163(12):2186-8. PubMed ID: 17151174 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a peripheral component in the sympatholytic actions of clonidine and guanfacine in man. Murphy MB; Brown MJ; Dollery CT Eur J Clin Pharmacol; 1984; 27(1):23-7. PubMed ID: 6386488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]